Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.

The molecular mechanisms underlying the relationship between low-density lipoprotein (LDL) and the risk of atherosclerosis are not clear. Therefore, detailed information on the protein composition of LDL may help to reveal its role in atherogenesis. Liquid-phase IEF has been used to resolve LDL prot...

Full description

Bibliographic Details
Main Authors: Banfi, C, Brioschi, M, Barcella, S, Wait, R, Begum, S, Galli, S, Rizzi, A, Tremoli, E
Format: Journal article
Language:English
Published: 2009
_version_ 1797095052181241856
author Banfi, C
Brioschi, M
Barcella, S
Wait, R
Begum, S
Galli, S
Rizzi, A
Tremoli, E
author_facet Banfi, C
Brioschi, M
Barcella, S
Wait, R
Begum, S
Galli, S
Rizzi, A
Tremoli, E
author_sort Banfi, C
collection OXFORD
description The molecular mechanisms underlying the relationship between low-density lipoprotein (LDL) and the risk of atherosclerosis are not clear. Therefore, detailed information on the protein composition of LDL may help to reveal its role in atherogenesis. Liquid-phase IEF has been used to resolve LDL proteins into well-defined fractions on the basis of pI, which improves the subsequent detection and resolution of low abundance proteins. Besides known LDL-associated proteins, this approach revealed the presence of proteins not previously described to reside in LDL, including prenylcysteine lyase (PCL1), orosomucoid, retinol-binding protein, and paraoxonase-1. PCL1, an enzyme crucial for the degradation of prenylated proteins, generates free cysteine, isoprenoid aldehyde and hydrogen peroxide. Addition of the substrate farnesylcysteine to lipoprotein resulted in a time-dependent generation of H(2)O(2) which was stronger in very low density lipoprotein (VLDL) than in LDL or HDL, reflecting the greater protein content of PCL1 in VLDL. Farnesol, a dead end inhibitor of the PCL1 reaction, reduced H(2)O(2) generation by VLDL. PCL1 is generated along with nascent lipoprotein, as shown by its presence in the lipoprotein secreted by HepG2 cells. The finding that an enzyme associated with atherogenic lipoproteins can itself generate an oxidant suggests that PCL1 may play a significant role in atherogenesis.
first_indexed 2024-03-07T04:22:31Z
format Journal article
id oxford-uuid:cb80e55c-c7b8-43ef-b7fd-a7143b83ca78
institution University of Oxford
language English
last_indexed 2024-03-07T04:22:31Z
publishDate 2009
record_format dspace
spelling oxford-uuid:cb80e55c-c7b8-43ef-b7fd-a7143b83ca782022-03-27T07:15:19ZProteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cb80e55c-c7b8-43ef-b7fd-a7143b83ca78EnglishSymplectic Elements at Oxford2009Banfi, CBrioschi, MBarcella, SWait, RBegum, SGalli, SRizzi, ATremoli, EThe molecular mechanisms underlying the relationship between low-density lipoprotein (LDL) and the risk of atherosclerosis are not clear. Therefore, detailed information on the protein composition of LDL may help to reveal its role in atherogenesis. Liquid-phase IEF has been used to resolve LDL proteins into well-defined fractions on the basis of pI, which improves the subsequent detection and resolution of low abundance proteins. Besides known LDL-associated proteins, this approach revealed the presence of proteins not previously described to reside in LDL, including prenylcysteine lyase (PCL1), orosomucoid, retinol-binding protein, and paraoxonase-1. PCL1, an enzyme crucial for the degradation of prenylated proteins, generates free cysteine, isoprenoid aldehyde and hydrogen peroxide. Addition of the substrate farnesylcysteine to lipoprotein resulted in a time-dependent generation of H(2)O(2) which was stronger in very low density lipoprotein (VLDL) than in LDL or HDL, reflecting the greater protein content of PCL1 in VLDL. Farnesol, a dead end inhibitor of the PCL1 reaction, reduced H(2)O(2) generation by VLDL. PCL1 is generated along with nascent lipoprotein, as shown by its presence in the lipoprotein secreted by HepG2 cells. The finding that an enzyme associated with atherogenic lipoproteins can itself generate an oxidant suggests that PCL1 may play a significant role in atherogenesis.
spellingShingle Banfi, C
Brioschi, M
Barcella, S
Wait, R
Begum, S
Galli, S
Rizzi, A
Tremoli, E
Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
title Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
title_full Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
title_fullStr Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
title_full_unstemmed Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
title_short Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
title_sort proteomic analysis of human low density lipoprotein reveals the presence of prenylcysteine lyase a hydrogen peroxide generating enzyme
work_keys_str_mv AT banfic proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT brioschim proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT barcellas proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT waitr proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT begums proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT gallis proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT rizzia proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme
AT tremolie proteomicanalysisofhumanlowdensitylipoproteinrevealsthepresenceofprenylcysteinelyaseahydrogenperoxidegeneratingenzyme